Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
Clinical trial NCT01690325 · TERMINATED
Trial details
- NCT number
- NCT01690325
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2016-11-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.